Be part of the knowledge - Global Oncology Academy

Popular

- Timothy A. McCarthy, MD
  Peer
2
CME/CE
Precision Oncology: Incorporating Next Generation Sequencing (NGS) in NSCLC
- James L. Gulley, MD, PhD, FACP
  Peer
- Scott Kopetz, MD, PhD, FACP
  Peer
- Luis Paz-Ares, MD, PhD
  Peer
5
CME/CE
Promising Bifunctional Agents in Immuno-Oncology: A Roundtable Discussion wit...
- Barnett Mennen, MD
  Peer
- James L. Gulley, MD, PhD, FACP
  Peer
21
CME/CE
Advances in Immuno-Oncology: Evaluating a Bispecific, Bifunctional Fusion Pro...
36
I-O Insights: Exploring Bifunctional Fusion Therapies
Innovative Molecules in Immuno-Oncology: Revolutionizing Cancer Treatment
- Robert Mocharnuk, MD
  Peer
- Jae Park, MD
  Peer
7
$Immunocellular Therapies for Relapsed/Refractory Heme Malignancies: A Focus on CAR T-Cell Therapy$ $Immunocellular Therapies for Relapsed/Refractory Heme Malignancies: A Focus on CAR T-Cell Therapy$
CME/CE
Immunocellular Therapies for Relapsed/Refractory Heme Malignancies: A Focus o...
- Shira Johnson, MD
  Peer
- Ronald DeMatteo, MD, FACS
  Peer
12
Medical Breakthroughs from Penn Medicine
What to Know About a State-of-the-Art Approach to GIST Treatment

Expert Perspectives

- Athanassios Argiris, MD, PhD, FACP
  Peer
2
Immuno-Oncology (IO) Updates
Role of Immunotherapy in Head & Neck Cancer
- Athanassios Argiris, MD, PhD, FACP
  Peer
2
FAQs with Key Opinion Leaders
Key Developments within Head & Neck Cancer
- Tanguy Seiwert, MD
  Peer
3
FAQs with Key Opinion Leaders
Targeted Therapy for Head & Neck Cancer
3
FAQs with Key Opinion Leaders
Novel Therapies for Head & Neck Cancer
2
Interviews
Current Updates on Squamous Cell Cancer of the Head and Neck (SCCHN)
- Makoto Tahara
  Peer
5
Interviews
Patient Case Study: Role of Cetuximab in treatment of SCC Head and Neck Cance...
9
Interviews
Interview with Makoto Tahara, MD, PhD | Japan
8
Interviews
Interview with Jan B. Vermorken, MD, PhD | Belgium

Join the Global Oncology Academy of learners.
Registration is free and easy.